91 related articles for article (PubMed ID: 25882637)
1. Canine heat shock protein 27 promotes proliferation, migration, and doxorubicin resistance in the canine cell line DTK-F.
Lin AC; Liao CW; Lin SW; Huang CY; Liou CJ; Lai YS
Vet J; 2015 Aug; 205(2):254-62. PubMed ID: 25882637
[TBL] [Abstract][Full Text] [Related]
2. Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines.
Hsiao YL; Hsieh TZ; Liou CJ; Cheng YH; Lin CT; Chang CY; Lai YS
BMC Vet Res; 2014 Sep; 10():229. PubMed ID: 25267010
[TBL] [Abstract][Full Text] [Related]
3. Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27.
Bakirel T; Alkan FÜ; Üstüner O; Çinar S; Yildirim F; Erten G; Bakirel U
J Vet Med Sci; 2016 May; 78(4):657-68. PubMed ID: 26822118
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of the KLF4 transcription factor inhibits the proliferation and migration of canine mammary tumor cells.
Tien YT; Chang MH; Chu PY; Lin CS; Liu CH; Liao AT
Vet J; 2015 Aug; 205(2):244-53. PubMed ID: 25616642
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein 27 is a potential indicator for response to YangZheng XiaoJi and chemotherapy agents in cancer cells.
Owen S; Zhao H; Dart A; Wang Y; Ruge F; Gao Y; Wei C; Wu Y; Jiang WG
Int J Oncol; 2016 Nov; 49(5):1839-1847. PubMed ID: 27600495
[TBL] [Abstract][Full Text] [Related]
6. Hsp-27 induction requires POU4F2/Brn-3b TF in doxorubicin-treated breast cancer cells, whereas phosphorylation alters its cellular localisation following drug treatment.
Fujita R; Ounzain S; Wang AC; Heads RJ; Budhram-Mahadeo VS
Cell Stress Chaperones; 2011 Jul; 16(4):427-39. PubMed ID: 21279488
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis.
Xu Y; Diao Y; Qi S; Pan X; Wang Q; Xin Y; Cao X; Ruan J; Zhao Z; Luo L; Liu C; Yin Z
Cell Signal; 2013 May; 25(5):1176-85. PubMed ID: 23357534
[TBL] [Abstract][Full Text] [Related]
8. Modulation of P-glycoprotein-mediated doxorubicin resistance in canine cell lines.
Page RL; Hughes CS; Huyan S; Sagris J; Trogdon M
Anticancer Res; 2000; 20(5B):3533-8. PubMed ID: 11131658
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.
Guillemette S; Rico C; Godin P; Boerboom D; Paquet M
J Mammary Gland Biol Neoplasia; 2017 Sep; 22(3):203-214. PubMed ID: 28822004
[TBL] [Abstract][Full Text] [Related]
10. Survivin and related proteins in canine mammary tumors: immunohistochemical expression.
Bongiovanni L; Romanucci M; Malatesta D; D'Andrea A; Ciccarelli A; Della Salda L
Vet Pathol; 2015 Mar; 52(2):269-75. PubMed ID: 24686389
[TBL] [Abstract][Full Text] [Related]
11. Localization of heat shock protein 110 in canine mammary gland tumors.
Okada S; Furuya M; Takenaka S; Fukui A; Matsubayashi M; Tani H; Sasai K
Vet Immunol Immunopathol; 2015 Oct; 167(3-4):139-46. PubMed ID: 26292766
[TBL] [Abstract][Full Text] [Related]
12. Canine gastric carcinoma: immunohistochemical expression of cell cycle proteins (p53, p21, and p16) and heat shock proteins (Hsp27 and Hsp70).
Carrasco V; Canfrán S; Rodríguez-Franco F; Benito A; Sáinz A; Rodríguez-Bertos A
Vet Pathol; 2011 Jan; 48(1):322-9. PubMed ID: 20587688
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of CD24 inhibits invasive growth, facilitates apoptosis and enhances chemosensitivity in gastric cancer AGS cells.
Jiao XL; Zhao C; Niu M; Chen D
Eur Rev Med Pharmacol Sci; 2013 Jul; 17(13):1709-15. PubMed ID: 23852892
[TBL] [Abstract][Full Text] [Related]
14. Masitinib reverses doxorubicin resistance in canine lymphoid cells by inhibiting the function of P-glycoprotein.
Zandvliet M; Teske E; Chapuis T; Fink-Gremmels J; Schrickx JA
J Vet Pharmacol Ther; 2013 Dec; 36(6):583-7. PubMed ID: 23363222
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of P-glycoprotein 1 (Pgp1, ABCB1)-mediated doxorubicin-resistant PLHC-1 hepatoma fish cell line.
Zaja R; Caminada D; Loncar J; Fent K; Smital T
Toxicol Appl Pharmacol; 2008 Mar; 227(2):207-18. PubMed ID: 18076962
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells.
Zhang D; Putti TC
Exp Cell Res; 2010 Dec; 316(20):3522-31. PubMed ID: 20833165
[TBL] [Abstract][Full Text] [Related]
17. The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines.
Oesterreich S; Weng CN; Qiu M; Hilsenbeck SG; Osborne CK; Fuqua SA
Cancer Res; 1993 Oct; 53(19):4443-8. PubMed ID: 8402609
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of heat shock protein 27 confers resistance to actinomycin D-induced apoptosis in cancer cells.
Ma W; Teng Y; Hua H; Hou J; Luo T; Jiang Y
FEBS J; 2013 Sep; 280(18):4612-24. PubMed ID: 23848600
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line.
Chen A; Ye S; Zheng J; Li J; Chen Z; Zhang Y; Li S
BMC Vet Res; 2023 Jan; 19(1):22. PubMed ID: 36717813
[TBL] [Abstract][Full Text] [Related]
20. A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro.
Rathore K; Cekanova M
Drug Des Devel Ther; 2015; 9():5323-35. PubMed ID: 26451087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
